Yes, but observe that the data in the image includes only "cases" with no discrimination for their severity. (I'm saying this because Ivory Hecker was once a Fox 26 reporter, supposedly dismissed for her bias/promotion of hydroxychloroquine [and of Stella Immanuel], among other things.)
The low/waning efficacy of the Pfizer vaccine purely in terms of cases in Israel has been covered the mainstream press as well, e.g. CNBC on July 23.
Pfizer and BioNTech’s Covid-19 vaccine is just 39% effective in Israel where the delta variant is the dominant strain, according to a new report from the country’s Health Ministry.
The two-dose vaccine still works very well in preventing people from getting seriously sick, demonstrating 88% effectiveness against hospitalization and 91% effectiveness against severe illness, according to the Israeli data.
100% of the fully sequenced cases in Israel have been the delta variant in the past month [July]. Also, at the end of July, Israel has announced [3rd] booster shots for the elderly who had their last vaccine dose 5 months before.
Preliminary data from a US study [preprint] (covered by the press today/yesterday), paints a somewhat similar picture.
Both vaccines [Pfizer=BNT162b2; Moderna=mRNA-1273] were highly effective during this study period against SARS-CoV-2 infection (mRNA-1273: 86%, 95%CI: 81-90.6%; BNT162b2: 76%, 95%CI: 69-81%) and COVID-19 associated hospitalization (mRNA-1273: 91.6%, 95% CI: 81-97%; BNT162b2: 85%, 95% CI: 73-93%). However, in July, the effectiveness against infection was considerably lower for mRNA-1273 (76%, 95% CI: 58-87%) with an even more pronounced reduction in effectiveness for BNT162b2 (42%, 95% CI: 13-62%).
(More newsworthy was the fact that this latter study suggests Moderna offered substantially more protection than Pfizer against mere infection, in multiple US states.)